Скачать или смотреть The NHS 10-year plan arrives – what are the highlights?

In today’s headlines - 3rd July 2025:

The UK government has raised the curtain on its new 10-year plan for the NHS, but there’s little detail on delivery.

The UK government's Neighbourhood Health Service is central to the NHS 10-year plan - but can it deliver real change?

Dizal gets US approval for an oral therapy for EGFR exon 20-mutated NSCLC, offering some patients an alternative to J&J's intravenous Rybrevant.

Novartis hopes of bringing Cosentyx to patients with giant cell arteritis seem to be over after the drug missed all the endpoints in a phase 3 trial.

Learn how Regeneron's bid to join the crowded US market for BCMA bispecifics for multiple myeloma has finally been realised.

Subscribe to ‪@Pharmaphorum‬ for daily news updates and check out www.pharmaphorum.com for more insights and analysis.

#pharmanews #pharmainnovation #newsoftheday #pharma #lifescience #biotechnews #biopharma #ukgovtnews #ukhealthcare #nhs #dizal #egfr #nscl #rybrevant #johnsonandjohnson #novartis #arteritis #drugdevelopment #clinicaltrial #clinicalresearch #regeneron #multiplemyeloma